Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides
- PMID: 1370586
- PMCID: PMC48320
- DOI: 10.1073/pnas.89.2.768
Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides
Abstract
We have demonstrated that the synthesis of cDNA by avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptases can be prevented by oligonucleotides bound to the RNA template approximately 100 nucleotides remote from the 3' end of the primer. The RNA was truncated at the level of the antisense oligonucleotide-RNA duplex during the reverse transcription. The key role played by the reverse transcriptase-associated RNase H activity in the inhibition process was shown by the use of (i) inhibitors of RNase H (NaF or dAMP), (ii) Moloney murine leukemia virus reverse transcriptase devoid of RNase H activity, or (iii) alpha-analogues of oligomers that do not elicit RNase H-catalyzed RNA degradation. In all three cases the inhibitory effect was either reduced (NaF, dAMP) or totally abolished. However, an alpha-oligomer bound to the sequence immediately adjacent to the primer-binding site prevented reverse transcription. Therefore, initiation of polymerization can be blocked by means of an RNase H-independent mechanism, whereas arrest of a growing cDNA strand can be achieved only by an oligonucleotide mediating cleavage of the template RNA.
Similar articles
-
Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.Nucleic Acids Symp Ser. 1993;(29):67-8. Nucleic Acids Symp Ser. 1993. PMID: 7504249
-
Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.J Mol Biol. 1999 Dec 17;294(5):1097-113. doi: 10.1006/jmbi.1999.3325. J Mol Biol. 1999. PMID: 10600369
-
Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.FEBS Lett. 1993 Sep 13;330(2):161-4. doi: 10.1016/0014-5793(93)80264-u. FEBS Lett. 1993. PMID: 7689980
-
[Inhibition of gene expression by antisense DNA].Nihon Rinsho. 1995 Mar;53(3):771-8. Nihon Rinsho. 1995. PMID: 7535367 Review. Japanese.
-
Is irrelevant cleavage the price of antisense efficacy?Pharmacol Ther. 2000 Mar;85(3):231-6. doi: 10.1016/s0163-7258(99)00053-4. Pharmacol Ther. 2000. PMID: 10739877 Review.
Cited by
-
Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10679-84. doi: 10.1073/pnas.93.20.10679. Proc Natl Acad Sci U S A. 1996. PMID: 8855239 Free PMC article.
-
Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.Nucleic Acids Res. 2012 Oct;40(19):9836-49. doi: 10.1093/nar/gks710. Epub 2012 Jul 25. Nucleic Acids Res. 2012. PMID: 22844088 Free PMC article.
-
Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.Nucleic Acids Res. 1994 Oct 11;22(20):4307-14. doi: 10.1093/nar/22.20.4307. Nucleic Acids Res. 1994. PMID: 7524038 Free PMC article.
-
The role of the 5' untranslated region of eukaryotic messenger RNAs in translation and its investigation using antisense technologies.Prog Nucleic Acid Res Mol Biol. 1994;48:181-238. doi: 10.1016/s0079-6603(08)60856-9. Prog Nucleic Acid Res Mol Biol. 1994. PMID: 7938549 Free PMC article. Review.
-
Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.J Virol. 2000 May;74(10):4621-33. doi: 10.1128/jvi.74.10.4621-4633.2000. J Virol. 2000. PMID: 10775598 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources